Increased levels of MMP-3, MMP-9 and MPO represent predictors of in-stent restenosis, while increased levels of ADMA, LCAT, ApoE and ApoD predict bare metal stent patency.

@article{Pleva2015IncreasedLO,
  title={Increased levels of MMP-3, MMP-9 and MPO represent predictors of in-stent restenosis, while increased levels of ADMA, LCAT, ApoE and ApoD predict bare metal stent patency.},
  author={Leos Pleva and Pavl{\'i}na Ku{\vs}nierov{\'a} and Pavl{\'i}na Plevov{\'a} and Jana Zapletalov{\'a} and Michal Karpisek and Lucie Faldynova and Petra Kovarova and Pavel Kukla},
  journal={Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia},
  year={2015},
  volume={159 4},
  pages={586-94}
}
AIMS We sought to identify biochemical predictors that indicate susceptibility to in-stent restenosis (ISR) after coronary artery bare-metal stenting. METHODS A total of 111 consecutive patients with post-percutaneous coronary intervention (PCI) in-stent restenosis of a target lesion within 12 months were matched for age, sex, vessel diameter, and diabetes with 111 controls without post-PCI ISR. Plasma or serum levels of biochemical markers were measured: matrix metalloproteinases (MMP) 2, 3… CONTINUE READING